THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) (FRA:9TH) operates under a 'Farm to Pharma' pharmaceutical model, now holding all three key cannabis licences being a Cannabis Research Licence, a Medicinal Cannabis Licence (Cultivation), and a Manufacture Licence through its domestic medicinal cannabis subsidiaries THC Pharma and Canndeo. THC Global has secured a significant cannabis growing capacity over multiple cultivation projects and owns a pharmaceuticals bio-manufacturing facility with attached testing and product development laboratory. THC Global is in prime position to commence medicinal cannabis production to service both domestic patients and the global export market. THC Global is active globally with operations in Australia, New Zealand, and Canada and partnerships across Europe, Asia, and the Middle East. In addition to its core Australian medicinal cannabis assets, THC Global has a significant Canadian presence – both in cannabis and in hydroponics equipment. THC Global's Canadian cannabis operation, Vertical Canna, holds property in Nova Scotia, Canada being developed into a large scale cannabis production site. THC Global's hydroponics equipment division, Crystal Mountain, is a revenue generating manufacturer, wholesaler, and retailer of hydroponic equipment and supplies.
THC Global Group Limited
ASX:THC ISIN:AU000000THC4
News
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) advises that the Company has appointed Mark Fortugno as the Group's new Chief Financial Officer. Mark's appointment follows Jarrod White advising the Company of his resignation and a subsequent executive search for an experienced CFO with cross-border transactional experience.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) through its wholly owned subsidiary Canndeo Limited has received two Cannabis Permits from the Office of Drug Control allowing the cultivation and production of the Company's proprietary high CBD strains at its Queensland growing and R&D facility.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) has secured exclusive rights to import Endoca's CBD products into New Zealand and has established a supply chain to patients through a strategic partnership with DATAPHARM.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) is pleased to advise that the Company's name has changed to THC Global Group Limited, from The Hydroponics Company Limited.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) advises that its wholly owned subsidiary, Vertical Canna Inc has entered into a binding agreement to conduct due diligence for the acquisition of a Canadian company which is in final stages of becoming a Licenced Producer of Cannabis.
The Hydroponics Company Limited, to be renamed THC Global Group Limited (subject to shareholder approval), (ASX:THC) (OTCMKTS:HDRPF) has commenced supply of Endoca CBD products to its first Australian patients.
The Hydroponics Company Limited, to be renamed THC Global Group Limited (subject to shareholder approval), (ASX:THC) (OTCMKTS:HDRPF) is pleased to provide an update to the market of its activities for the quarter ended 30 September 2018.
The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF) (to be renamed THC Global Group Limited) provides the following information with respect to its Canadian operations.
The Hydroponics Company Ltd (ASX:THC) (OTCMKTS:HDRPF) provides the Company's latest Investor Update Presentation.
Your directors present their report, together with the financial statements, on the consolidated entity consisting of The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF) and the entities it controlled at the end of, or during, the half-year ended 30 June 2018.
41,664 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 115) (Last 30 Days: 512) (Since Published: 41664)